Table 4.
HR* (CI 95%) | p value | Adj HR*# (CI 95%) | p value | p value Interaction*# (depression symptoms x instrument) | |
---|---|---|---|---|---|
Instrument | |||||
SF-12 | |||||
PCS | 0.80 (0.75–0.85) | <0.001 | 0.87 (0.82–0.93) | <0.001 | 0.94 |
MCS | 0.90 (0.85–0.95) | <0.001 | 0.94 (0.89–1.01) | 0.078 | 0.66 |
EQ-5D | 0.84 (0.80–0.89) | <0.001 | 0.89 (0.84–0.95) | <0.001 | 0.59 |
SF-36 (Vitality) | 0.83 (0.79–0.88) | <0.001 | 0.91 (0.85–0.96) | 0.002 | 0.25 |
EORTC QLQ-30^ | 1.18 (1.12–1.25) | <0.001 | 1.09 (1.03–1.16) | 0.004 | 1.00 |
EORTC QLQ-LC13 | 1.24 (1.18–1.31) | <0.001 | 1.14 (1.08–1.21) | <0.001 | 0.008 |
Powe Fatalism Inventory^ | 0.95 (0.90–1.01) | 0.11 | 0.96 (0.90–1.03) | 0.25 | 0.38 |
MOS Social Support Survey^ | |||||
Emotional/Informational | 0.96 (0.91–1.02) | 0.21 | 1.01 (0.95–1.07) | 0.71 | 0.04 |
Tangible/instrumental | 0.96 (0.91–1.01) | 0.12 | 0.98 (0.93–1.04) | 0.53 | 0.26 |
Scores standardized to unit of one standard deviation for comparison;
Adjusted by age, race, sex, income, education, smoking history, marital status, comorbidities and cancer stage and histology;
Selected items
Abbreviations: SF-12= Medical Outcomes Study 12-item short form, EQ-5D=EuroQol questionnaire, SF-36 Medical Outcomes Study 36-item short form vitality scale, EORTC QLQ-30= European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, LC-13=Lung Cancer Modular Questionnaire, and MOS=Medical Outcomes Study.